Palladium-Catalyzed Oxidative Aminocarbonylation
7.28–7.18 (m, 2 H), 3.86–3.80 (m, 2 H), 3.77–3.73 (m, 2 H), 3.70
7.2 Hz, 1 H), 4.00–3.90 (m, 2 H), 3.82–3.77 (m, 2 H), 3.77–3.50 (m,
(s, 4 H), 2.35 (s, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 153.3, 4 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 153.2, 133.2, 133.0,
138.3, 132.8, 131.1, 129.5, 128.4, 120.0, 91.4, 80.4, 66.9, 66.5, 47.3,
41.9, 21.1 ppm. HRMS (ESI, TOF): calcd. for C14H16NO2 [M +
H]+ 230.1181; found 230.1182.
132.1, 130.7, 128.5, 127.5, 126.8, 125.6, 125.1, 117.8, 89.6, 85.3,
66.9, 66.5, 47.4, 42.0 ppm. HRMS (ESI, TOF): calcd. for
C17H16NO2 [M + H]+ 266.1181; found 266.1178.
3-(Biphenyl-4-yl)-1-morpholinoprop-2-yn-1-one (3ja): 3-(Biphenyl-4-
yl)propiolic acid (1j, 0.667 g, 3.0 mmol) and morpholine (2a,
0.784 g, 9.0 mmol) afforded product 3ja (0.576 g, 1.98 mmol, 66%
1-Morpholino-3-p-tolylprop-2-yn-1-one (3da): 3-p-Tolylpropiolic
acid (1d, 0.481 g, 3.0 mmol) and morpholine (2a, 0.784 g,
9.0 mmol) afforded product 3da (0.529 g, 2.31 mmol, 77% yield) as
1
1
yield) as a yellow solid; m.p. 129.0–130.0 °C. H NMR (300 MHz,
a yellow solid; m.p. 88.0–89.0 °C. H NMR (300 MHz, CDCl3): δ
CDCl3): δ = 7.65–7.56 (m, 6 H), 7.50–7.42 (m, 2 H), 7.42–7.34 (m,
1 H), 3.93–3.83 (m, 2 H), 3.81–3.75 (m, 2 H), 3.72 (s, 4 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 153.2, 143.0, 139.8, 132.8, 128.9,
128.1, 127.2, 127.1, 119.0, 91.2, 81.3, 66.9, 66.5, 47.3, 42.0 ppm.
HRMS (ESI, TOF): calcd. for C19H18NO2 [M + H]+ 292.1338;
found 292.1336.
= 7.51–7.38 (m, 2 H), 7.21–7.13 (m, 2 H), 3.84 (ddd, J = 4.6, 2.9,
1.1 Hz, 2 H), 3.75 (ddd, J = 4.5, 2.8, 1.1 Hz, 2 H), 3.70 (s, 4 H),
2.38 (s, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 153.3, 140.7,
132.3, 129.3, 117.1, 91.5, 80.3, 66.8, 66.4, 47.2, 41.9, 21.6 ppm.
HRMS (ESI, TOF): calcd. for C14H16NO2 [M + H]+ 230.1181;
found 230.1179.
3-(4-Acetylphenyl)-1-morpholinoprop-2-yn-1-one (3ka): 3-(4-Acet-
ylphenyl)propiolic acid (1k, 0.565 g, 3.0 mmol) and morpholine
(2a, 0.784 g, 9.0 mmol) afforded product 3ka (0.409 g, 1.59 mmol,
53% yield) as a yellow solid; m.p. 128.0–129.0 °C. 1H NMR
(300 MHz, CDCl3): δ = 7.99–7.88 (m, 2 H), 7.69–7.57 (m, 2 H),
3.84 (ddd, J = 6.8, 5.1, 2.9 Hz, 2 H), 3.77 (ddd, J = 4.6, 2.5, 0.9 Hz,
2 H), 3.72 (s, 4 H), 2.62 (s, 3 H) ppm. 13C NMR (75 MHz, CDCl3):
δ = 197.0, 152.7, 137.7, 132.5, 128.3, 124.9, 89.8, 83.1, 66.9, 66.4,
47.3, 42.0, 26.7 ppm. HRMS (ESI, TOF): calcd. for C15H16NO3
[M + H]+ 258.1130; found 258.1127.
3-(2,4-Dimethylphenyl)-1-morpholinoprop-2-yn-1-one (3ea): 3-(2,4-
Dimethylphenyl)propiolic acid (1e, 0.523 g, 3.0 mmol) and morph-
oline (2a, 0.784 g, 9.0 mmol) afforded product 3ea (0.518 g,
2.13 mmol, 71% yield) as a yellow oil. 1H NMR (300 MHz,
CDCl3): δ = 7.41 (d, J = 7.8 Hz, 1 H), 7.05 (s, 1 H), 6.99 (d, J =
8.8 Hz, 1 H), 3.91–3.81 (m, 2 H), 3.75 (dt, J = 6.4, 4.3 Hz, 2 H),
3.71 (s, 4 H), 2.43 (s, 3 H), 2.34 (s, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 153.4, 141.1, 140.6, 132.8, 130.5, 126.6, 117.0, 90.7,
84.0, 66.8, 66.4, 47.2, 41.9, 21.5, 20.6 ppm. HRMS (ESI, TOF):
calcd. for C15H18NO2 [M + H]+ 244.1338; found 244.1337.
Methyl 4-(3-Morpholino-3-oxoprop-1-ynyl)benzoate (3la): 3-[4-
(Methoxycarbonyl)phenyl]propiolic acid (1l, 0.613 g, 3.0 mmol)
and morpholine (2a, 0.784 g, 9.0 mmol) afforded product 3la
(0.369 g, 1.35 mmol, 45% yield) as a yellow solid; m.p. 125.0–
126.0 °C. 1H NMR (300 MHz, CDCl3): δ = 8.14–7.95 (m, 2 H),
7.80–7.33 (m, 2 H), 3.94 (s, 3 H), 3.90–3.81 (m, 2 H), 3.81–3.74 (m,
2 H), 3.71 (s, 4 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 166.1,
152.7, 132.2, 131.3, 129.6, 124.7, 89.8, 82.8, 66.8, 66.4, 52.4, 47.3,
42.0 ppm. HRMS (ESI, TOF): calcd. for C15H16NO4 [M + H]+
274.1079; found 274.1078.
3-(2-Methoxyphenyl)-1-morpholinoprop-2-yn-1-one (3fa): 3-(2-
Methoxyphenyl)propiolic acid (1f, 0.529 g, 3.0 mmol) and morph-
oline (2a, 0.784 g, 9.0 mmol) afforded product 3fa (0.537 g,
2.19 mmol, 73% yield) as a yellow solid; m.p. 91.0–92.0 °C. 1H
NMR (300 MHz, CDCl3): δ = 7.61–7.47 (m, 1 H), 7.39 (ddd, J =
8.4, 7.5, 1.8 Hz, 1 H), 7.06–6.77 (m, 2 H), 3.99–3.91 (m, 2 H), 3.88
(s, 3 H), 3.80–3.73 (m, 2 H), 3.70 (s, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 161.1, 153.4, 134.2, 131.8, 120.5, 110.6, 109.5, 87.8,
84.9, 66.9, 66.5, 55.7, 47.2, 41.9 ppm. HRMS (ESI, TOF): calcd.
for C14H16NO3 [M + H]+ 246.1130; found 246.1130.
4-(3-Morpholino-3-oxoprop-1-ynyl)benzonitrile (3ma): 3-(4-Cyano-
phenyl)propiolic acid (1m, 0.514 g, 3.0 mmol) and morpholine (2a,
0.784 g, 9.0 mmol) afforded product 3ma (0.339 g, 1.41 mmol, 47%
1-Morpholino-3-(3,4,5-trimethoxyphenyl)prop-2-yn-1-one (3ga): 3-
(3,4,5-Trimethoxyphenyl)propiolic acid (1g, 0.709 g, 3.0 mmol) and
morpholine (2a, 0.784 g, 9.0 mmol) afforded product 3ga (0.494 g,
1.62 mmol, 54% yield) as a yellow solid; m.p. 145.0–146.0 °C. 1H
NMR (300 MHz, CDCl3): δ = 6.79 (s, 2 H), 3.87 (d, J = 3.8 Hz, 9
H), 3.85–3.81 (m, 2 H), 3.77 (dd, J = 5.5, 3.6 Hz, 2 H), 3.70 (s, 4
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 153.02, 152.99, 140.3,
114.8, 109.6, 91.3, 79.8, 66.7, 66.3, 60.8, 56.1, 47.1, 41.8 ppm.
HRMS (ESI, TOF): calcd. for C16H20NO5 [M + H]+ 306.1341;
found 306.1340.
1
yield) as a yellow solid; m.p. 198.0–199.0 °C. H NMR (300 MHz,
CDCl3): δ = 7.71–7.66 (m, 2 H), 7.66–7.60 (m, 2 H), 3.85–3.79 (m,
2 H), 3.79–3.74 (m, 2 H), 3.72 (s, 4 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 152.3, 132.7, 132.2, 125.0, 117.9, 113.6, 88.6, 83.9,
66.8, 66.4, 47.3, 42.0 ppm. HRMS (ESI, TOF): calcd. for
C14H13N2O2 [M + H]+ 241.0977; found 241.0979.
N,N-Dipropyl-3-m-tolylpropiolamide (3ch): 3-m-Tolylpropiolic acid
(1c, 0.481 g, 3.0 mmol) and dipropylamine (2h, 0.911 g, 9.0 mmol)
afforded product 3ch (0.504 g, 2.07 mmol, 69% yield) as a yellow
oil. 1H NMR (300 MHz, CDCl3): δ = 7.35–7.28 (m, 2 H), 7.25–
7.19 (m, 2 H), 3.60–3.55 (m, 2 H), 3.39–3.35 (m, 2 H), 2.35 (s, 3 H),
1.76–1.55 (m, 4 H), 1.02–0.90 (m, 6 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 154.6, 138.2, 132.7, 130.7, 129.4, 128.4, 120.6, 89.5,
81.8, 50.8, 46.5, 22.2, 21.2, 20.7, 11.4, 11.3 ppm. HRMS (ESI,
TOF): calcd. for C16H22NO [M + H]+ 244.1701; found 244.1699.
3-(4-Fluorophenyl)-1-morpholinoprop-2-yn-1-one (3ha): 3-(4-Fluoro-
phenyl)propiolic acid (1h, 0.492 g, 3.0 mmol) and morpholine (2a,
0.784 g, 9.0 mmol) afforded product 3ha (0.476 g, 2.04 mmol, 68%
yield) as a yellow solid; m.p. 94.0–95.0 °C. 1H NMR (300 MHz,
CDCl3): δ = 7.64–7.44 (m, 2 H), 7.16–7.00 (m, 2 H), 3.88–3.80 (m,
2 H), 3.80–3.73 (m, 2 H), 3.71 (s, 4 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 165.6 (d, J = 251.3 Hz), 153.0, 134.5 (d, J = 8.7 Hz),
116.3 (d, J = 3.5 Hz), 116.0 (d, J = 22.1 Hz), 90.1, 80.6, 66.8, 66.4,
47.3, 41.9 ppm. HRMS (ESI, TOF): calcd. for C13H13NO2F [M +
H]+ 234.0930; found 234.0932.
N,N-Dipropyl-3-p-tolylpropiolamide (3dh): 3-p-Tolylpropiolic acid
(1d, 0.481 g, 3.0 mmol) and dipropylamine (2h, 0.911 g, 9.0 mmol)
afforded product 3dh (0.452 g, 1.86 mmol, 62% yield) as a yellow
oil. 1H NMR (300 MHz, CDCl3): δ = 7.49–7.35 (m, 2 H), 7.17 (dd,
J = 8.4, 0.6 Hz, 2 H), 3.66–3.50 (m, 2 H), 3.43–3.30 (m, 2 H), 2.37
(s, 3 H), 1.73–1.58 (m, 4 H), 0.95 (dt, J = 14.6, 7.4 Hz, 6 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 154.7, 140.3, 132.2, 129.2, 117.7,
1-Morpholino-3-(naphthalen-1-yl)prop-2-yn-1-one (3ia): 3-(Naphth-
alen-1-yl)propiolic acid (1i, 0.589 g, 3.0 mmol) and morpholine (2a,
0.784 g, 9.0 mmol) afforded product 3ia (0.517 g, 1.95 mmol, 65%
1
yield) as a yellow oil. H NMR (300 MHz, CDCl3): δ = 8.27 (dd,
J = 8.2, 0.8 Hz, 1 H), 7.96–7.85 (m, 2 H), 7.80 (dd, J = 7.2, 1.2 Hz, 89.6, 81.7, 50.8, 46.5, 22.2, 21.6, 20.7, 11.4, 11.3 ppm. HRMS (ESI,
1 H), 7.65–7.58 (m, 1 H), 7.58–7.51 (m, 1 H), 7.46 (dd, J = 8.3, TOF): calcd. for C16H22NO [M + H]+ 244.1701; found 244.1700.
Eur. J. Org. Chem. 2015, 2235–2243
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2241